MARC Record from marc_columbia

LEADER: 03390cam a2200337Ia 4500
001 5773972
005 20221121203857.0
008 060407t20062006nyu 001 0 eng d
016 7 $a977549879$2GyFmDB
020 $a038729984X (hd.bd.)
029 0 $aOHX$bhar050151904
035 $a(OCoLC)ocm68629174
035 $a(NNC)5773972
035 $a5773972
040 $aOHX$cOHX$dBAKER$dVET$dCUS$dNNC-M$dOrLoB-B
072 7 $aRC$2lcco
090 $aRC382$b.R43 2006
096 $aWL 359$bR436 2006
245 00 $aRestorative therapies in Parkinson's disease /$cPatrik Brundin, C. Warren Olanow, editors.
260 $aNew York, NY :$bSpringer,$c[2006], ©2006.
300 $axvii, 365 pages, 16 unnumbered pages of plates :$billustrations (some color) ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tRestorative therapies for Parkinson's disease : current status and future perspectives /$rAnders Bjorklund -- $g2.$tRestorative therapies for Parkinson's disease : ethical issues /$rGerard J. Boer -- $g3.$tEvolution of Parkinson's disease and treatment requirements : what new treatments are needed and the role of striatal grafting /$rJose A. Obeso and Anthony E. Lang -- $g4.$tClinical trial design issues /$rKarl Kieburtz -- $g5.$tLessons learned from early clinical neural grafting in Parkinson's disease /$rPierre Cesaro and Hakan Widner -- $g6.$tFetal nigral transplantation as a therapy for Parkinson's disease /$rC. W. Olanow and S. Fahn -- $g7.$tImaging of the Parkinsonian brain in relation to restorative therapy /$rA. Jon Stoessl, Vesna Sossi and David J. Brooks -- $g8.$tImportant aspects of surgical methodology for transplantation in Parkinson's disease /$rThomas B. Freeman and Patrik Brundin -- $g9.$tHistopathological and clinical criteria for analyzing transplanted human dopamine cells in Parkinson's disease /$rOle Isacson, Nicholas Lange, Oliver Cooper and Rosario Sanchez-Pernaute -- $g10.$tDyskinesias and neural grafting in Parkinson's disease /$rM. Angela Cenci and Peter Hagell -- $g11.$tPorcine neural xenotransplantation : current status /$rRoger A. Barker and Mark Sayles -- $g12.$tAdult-derived stem cells for transplantation in Parkinson's disease /$rXinyu Zhao, D. Chichung Lie and Fred H. Gage -- $g13.$tEmbryonic stem cells for grafting in Parkinson's disease /$rViviane Tabar and Lorenz Studer -- $g14.$tGenetically modified cells as a source for grafting in Parkinson's disease /$rHyun-Jung Kim, Gesine Paul, Yu-Tzu Tai and Clive N. Svendsen -- $g15.$tDelivery of GDNF for Parkinson's disease : transition of a neuroprotective treatment strategy from basic sciences to clinical application /$rDeniz Kirik, Biljana Georgievska, Soshana Behrstock and Clive Niels Svendsen -- $g16.$tIn vivo gene therapy as a potential treatment for Parkinson's disease /$rCaryl E. Sortwell and Jeffrey H. Kordower.
650 0 $aParkinson's disease$xTreatment.
650 2 $aParkinson Disease$xrehabilitation.$0https://id.nlm.nih.gov/mesh/D010300Q000534
650 2 $aParkinson Disease$xtherapy.$0https://id.nlm.nih.gov/mesh/D010300Q000628
700 1 $aBrundin, Patrik.$0http://id.loc.gov/authorities/names/n2006183800
700 1 $aOlanow, C. W.$q(Charles Warren),$d1941-$0http://id.loc.gov/authorities/names/n92801065
852 00 $boff,hsl$hRC382$i.R43 2006